Media Tour of Hemofarm

Representatives of leading national media have visited Hemofarm’s complex in Vršac today. After an informal conversation with Ronald Seeliger, Chief Executive Officer, and Sanda Savić, Director of Corporate Affairs and Communications, the journalists made a tour of Solid Dosage Forms Plant and High Bay Warehouse with Dejan Ivanović, Director of Production.

Hemofarm has entered the year in which it marks 55 years of growth and development with impressive results and a record production in all factories – both in terms of the number of packs, and in the number of produced units! With more than 200 million packs and 4 billion tablets manufactured last year, Hemofarm has recorded a historic growth for the fifth consecutive year.Since 2010, Hemofarm has doubled production, the capacity of which is a million tablets per hour!

"In 2014, we strengthened the leading position in the pharmaceutical market of Serbia and the region, as well as the status of the major exporter in the sector, and one of the largest exporters from the country. In spite of a very challenging situation in our field of operation, which also resulted in the reduction of prices of medicines, I am proud of new records that we achieved. This year, when we mark a jubilee, 55 years of Hemofarm’s existence, new investments in the amount of more than EUR 20 million, have been planned with the aim of expanding production capacities and constructing new facilities. In accordance with sustainable development principles, as integral and strategic orientation of Hemofarm, by continuous investments in production and warehousing modernization, we practically give a positive impetus to environmental protection. By the quality of business operation and products, relation to employees and community, as well as the activity of our Foundation Hemofarm, we have been trying to contribute to improvement of the overall healthcare system and entire society", Ronald Seeliger said in an informal gathering with journalists.

Besides the planned expansion of the capacities of ampule forms in Vršac, several-million worth investments in the plant for production of nasal sprays in the factory Hemomont in Podgorica, have been planned this year.

"Top quality and safety of Hemofarm’s products were verified by 26 domestic and international audits in all our factories only in the course of the previous year. Apart from the historical volume, we also achieved a record complexity of production, enlarged portfolio by 15% by launching more than two thousand products to the Serbian and international markets in 2014", Dejan Ivanović, Director of Hemofarm Production, pointed out.

Sanda Savić, Director of Corporate Affairs and Communications, also addressed the journalists and reminded that Foundation Hemofarm would intensify the national campaign WHOLEHEARTEDLY this year, putting the focus on the support to healthcare system, which is in accordance with the mission of Hemofarm, announcing that the first action to ensue is a humanitarian auction of paintings, by which the refurbishment of the Children Theatre Boško Buha will be additionally supported, by financial aid of EUR 30,000.

Media representatives were delighted with the cutting-edge technologies and most sophisticated processes of pharmaceuticals production, packaging and warehousing, which are applied in our company.